These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 6693051

  • 21. [Prognostic significance of the length of the uterus, depth of infiltration and grading of endometrium cancer].
    Elling D, Schildhaus I, Götze W, Bartel U.
    Zentralbl Gynakol; 1990; 112(2):75-9. PubMed ID: 2316298
    [Abstract] [Full Text] [Related]

  • 22. CD10 imunostaining does not distinguish endometrial carcinoma invading myometrium from carcinoma involving adenomyosis.
    Srodon M, Klein WM, Kurman RJ.
    Am J Surg Pathol; 2003 Jun; 27(6):786-9. PubMed ID: 12766582
    [Abstract] [Full Text] [Related]

  • 23. [Histology and prognosis of endometrial carcinoma].
    Sakamoto A, Hirai Y, Yamauchi K, Kitagawa T, Sugano H, Masubuchi K, Hasumi K.
    Gan No Rinsho; 1987 Dec; 33(15):1897-900. PubMed ID: 3430742
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Significance of adenomyosis on tumor progression and survival outcome of endometrial cancer.
    Matsuo K, Cahoon SS, Gualtieri M, Scannell CA, Jung CE, Takano T, Paulson RJ, Muderspach LI, Roman LD.
    Ann Surg Oncol; 2014 Dec; 21(13):4246-55. PubMed ID: 25001096
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Prognostic factors of endometrial carcinoma: a study of 98 cases].
    Yin LJ.
    Zhonghua Fu Chan Ke Za Zhi; 1993 Mar; 28(3):150-2, 188. PubMed ID: 8354094
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Stromal invasion in endometrial adenocarcinoma.
    King A, Seraj IM, Wagner RJ.
    Am J Obstet Gynecol; 1984 May 01; 149(1):10-4. PubMed ID: 6720760
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. T2 relaxometry mapping in demonstrating layered uterine architecture: parameter optimization and utility in endometrial carcinoma and adenomyosis: a feasibility study.
    Ghosh A, Singh T, Bagga R, Srinivasan R, Singla V, Khandelwal N.
    Br J Radiol; 2018 Jan 01; 91(1081):20170377. PubMed ID: 28936889
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.
    Alektiar KM, McKee A, Lin O, Venkatraman E, Zelefsky MJ, Mychalczak BR, McKee B, Hoskins WJ, Barakat RR.
    Cancer; 2002 Jul 15; 95(2):316-21. PubMed ID: 12124832
    [Abstract] [Full Text] [Related]

  • 40. A clinicopathologic study of endometrial carcinoma with special reference to new histological variants.
    Sato Y, Ozaki M, Ueda G, Tanizawa O.
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jun 15; 37(6):1015-9. PubMed ID: 2991395
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.